Wagner H J, Rager G
Abteilung Strahlendiagnostik, Klinikum Philipps-Universität Marburg.
Rofo. 1998 May;168(5):415-20. doi: 10.1055/s-2007-1015156.
Although percutaneous transluminal angioplasty (PTA) has become established as an endovascular technique--in the more strict sense as a balloon dilatation but being increasingly supplemented by stent implantations--for many vascular regions, reports on infrapopliteal angioplasties are rather scarce. With the development of hydrophilically coated guide wires, improved catheter materials, and dedicated balloon catheters for infrapopliteal use, dilatation treatments distal of the popliteal artery are now standard procedures. Major advances in peri-interventional drug management have also made their contribution. The initial technical and clinical results obtained are excellent. For the majority of the patients, the main concern is for limb salvage. In this context, infrapopliteal PTA also achieves satisfactory results. However, the long-term results must still be considered as unsatisfactory since recurrences are frequent and require repeat interventions. Therefore new therapeutic strategies are required that can reduce re-stenoses especially in this peripheral vascular segment.
尽管经皮腔内血管成形术（PTA）已成为一种血管内技术——从更严格的意义上讲是球囊扩张术，但越来越多地辅以支架植入——用于许多血管区域，但关于腘动脉以下血管成形术的报道却相当稀少。随着亲水涂层导丝、改良导管材料以及用于腘动脉以下的专用球囊导管的发展，腘动脉远端的扩张治疗现已成为标准程序。围介入期药物管理的重大进展也发挥了作用。最初获得的技术和临床结果非常出色。对于大多数患者来说，主要关注点是保肢。在这种情况下，腘动脉以下PTA也取得了令人满意的结果。然而，长期结果仍被认为不尽人意，因为复发频繁且需要重复干预。因此，需要新的治疗策略来减少再狭窄，尤其是在这个外周血管段。
